{"resourceType": "Group", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-group"], "versionId": "44", "lastUpdated": "2024-08-02T00:37:03.642Z"}, "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Computable Publishing\u00ae: MAGIC-to-FEvIR Converter"}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact", "valueRelatedArtifact": {"type": "part-of", "label": "Part of", "display": "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes", "resource": "https://fevir.net/resources/Composition/236363"}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-title", "valueString": "GLP-1 RA Group in Adults with type 2 diabetes"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-url", "valueUri": "https://fevir.net/resources/Group/236948"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-publisher", "valueString": "Computable Publishing LLC"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-copyright", "valueMarkdown": "https://creativecommons.org/licenses/by-nc-sa/4.0/"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-useContext", "valueUsageContext": {"code": {"system": "https://fevir.net/resources/CodeSystem/179423", "code": "evidence-communication", "display": "Evidence Communication"}, "valueCodeableConcept": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/179423", "code": "ComparatorGroup", "display": "ComparatorGroup"}]}}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-contact", "valueContactDetail": {"telecom": [{"system": "email", "value": "support@computablepublishing.com"}]}}, {"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/combination-method", "valueCode": "all-of"}], "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "system": "https://fevir.net", "value": "236948", "assigner": {"display": "Computable Publishing LLC"}}, {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-comparator-group-MAGIC-5288-j1Wqrn-comparator-85394-C-85798", "assigner": {"display": "Computable Publishing LLC"}}], "description": "Glucagon-Like Peptide-1 (GLP-1) receptor agonists", "membership": "enumerated", "characteristic": [{"code": {"text": "Member of"}, "valueReference": {"type": "Group", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-population-group-85394-85798", "assigner": {"display": "Computable Publishing LLC"}}, "display": "Adults with type 2 diabetes and CVD and CKD", "reference": "Group/236947"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "inclusion in Adults with type 2 diabetes"}]}, {"code": {"text": "Exposed to"}, "valueReference": {"type": "Group", "identifier": {"type": {"text": "FEvIR Linking Identifier"}, "system": "https://fevir.net/FLI", "value": "MAGIC-5288-j1Wqrn-comparator-85394-C-85798", "assigner": {"display": "Computable Publishing LLC"}}, "display": "Glucagon-Like Peptide-1 (GLP-1) receptor agonists", "reference": "Group/236776"}, "exclude": false, "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/characteristic-description", "valueMarkdown": "received GLP-1 RA"}]}], "id": "236948", "modifierExtension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-status", "valueCode": "active"}], "type": "animal"}